title: Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients.
authors.affiliation: Department of Surgery, Queen Elizabeth Hospital, Bonham Road, Hong Kong. patvic@netvigator.com
authors.forename: Wing-Hong
authors.initials: WH
authors.lastname: Li
authors.forename: Ka-Wing
authors.initials: KW
authors.lastname: Ma
authors.forename: Mina
authors.initials: M
authors.lastname: Cheng
authors.forename: King-Him
authors.initials: KH
authors.lastname: Chui
authors.forename: Pat-Tat
authors.initials: PT
authors.lastname: Chan
authors.forename: Wai-Ho
authors.initials: WH
authors.lastname: Chu
authors.forename: Hon-Shing
authors.initials: HS
authors.lastname: Fung
authors.forename: Chong-Hei
authors.initials: CH
authors.lastname: Kowk
authors.forename: Moon-Tong
authors.initials: MT
authors.lastname: Cheung
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery*; D017115:Catheter Ablation; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D000509:alpha-Fetoproteins